Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Nov 15, 2023; 15(11): 1936-1950
Published online Nov 15, 2023. doi: 10.4251/wjgo.v15.i11.1936
Published online Nov 15, 2023. doi: 10.4251/wjgo.v15.i11.1936
Figure 2 Dopamine and cyclic adenosine monophosphate regulated phosphoprotein with an apparent Mr of 32000 promotes colorectal cancer proliferation in vitro.
A and B: Detecting the expression level of dopamine and cyclic adenosine monophosphate regulated phosphoprotein with an apparent Mr of 32000 (DARPP-32) by western blot analysis in HCT116/SW480 stable cell lines overexpressing DARPP-32 and in HT-29/LOVO cell lines with DARPP-32 knockdown; C-G: DARPP-32 overexpression promoted the growth of HCT116 and SW480 cells by ethynyl-2′-deoxyuridine (EdU) and Cell Counting Kit-8 (CCK-8) (black scale bars, 100 μm); H-K: Representative images of the proliferative capabilities of cells in HT-29 and LOVO cells with small interfering RNA (siRNA) knockdown of DARPP-32 detected by EdU and CCK-8 (black scale bars, 100 μm). aP < 0.05; bP < 0.01; cP < 0.001; dP < 0.0001. GAPDH: Glyceraldehyde-3-phosphate dehydrogenase; NC: Negative control.
- Citation: He K, Xie CZ, Li Y, Chen ZZ, Xu SH, Huang SQ, Yang JG, Wei ZQ, Peng XD. Dopamine and cyclic adenosine monophosphate-regulated phosphoprotein with an apparent Mr of 32000 promotes colorectal cancer growth. World J Gastrointest Oncol 2023; 15(11): 1936-1950
- URL: https://www.wjgnet.com/1948-5204/full/v15/i11/1936.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i11.1936